Poland· PL-100003120

Aescin

A heparin, kombinationen product containing escinum + diethylamini salicylas + heparinum, registered in Poland by Teva Pharmaceuticals Polska Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.

ATC C05BA53

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAescinATCC05BA53REGISTER NO.PL-100003120PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Heparin, kombinationen is registered in 2 of 19 countries.

Countries holding a registration under ATC C05BA53 (heparin, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Heparin, kombinationen · ATC C05BA53

2 / 19 countries

  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Escinum + Diethylamini salicylas + Heparinum
Manufacturer
Teva Pharmaceuticals Polska Sp. z o.o.
Country
Poland (PL)
ATC code
C05BA53
ATC class
Heparin, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990126019
  • gtin
    05909990126026

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/018be182-4522-4948-b903-51ccaf9f6f2a
GET /v1/drugs/018be182-4522-4948-b903-51ccaf9f6f2a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Żel",
  "source": "urpl",
  "strength": "(20 mg + 50 mg + 50 j.m.)/g",
  "packaging": "05909990126019 ¦ OTC ¦ 516\n1 op. 40 g\n05909990126026 ¦ OTC ¦ Skasowane ¦ 517\n1 op. 100 g",
  "substance": "Escinum 20 mg/g + Diethylamini salicylas 50 mg/g + Heparinum natricum 50 j.m./g",
  "common_name": "Escinum + Diethylamini salicylas + Heparinum",
  "pl_product_id": "100003120",
  "pozwolenie_nr": "01260",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about heparin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.